OK luck let’s be honest here. Early biotech’s always need money and when shorts come in and squeeze them even if they have good concepts have good trials they still go bankrupt because they cannot get cash in fusion. I have seen this countless times and unfortunately I bit on this one which was a big big mistake. It’s never that they are bad companies well yes they can have bad management and bad boards but great ideas but it takes a long time to see it through the finish line, when you can’t get money, they go into the trash pile. Like I said earlier, I have seen this countless times it is what it is but good luck to you on your next investment. BTW, the person that I put a lot of faith in in Dallas, who was a very good investor, but he was a short fund investor for a very long time which makes me wonder if he did it again. I’m not saying he misled me, but one has to wonder.